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Hepatocellular carcinoma (HCC) represents the ﬁfth-most common form of cancer worldwide and carries a high mortality
rate attributed to lack of effective treatment. Males are 8 times more likely to develop HCC than females, an effect largely
driven by sex hormones, albeit through still poorly understood mechanisms. We previously identiﬁed TRIM28 (tripartite
protein 28), a scaffold protein capable of recruiting a number of chromatin modiﬁers, as a crucial mediator of sexual
dimorphism in the liver. Trim28hep–/– mice display sex-speciﬁc transcriptional deregulation of a wide range of bile and ste-
roid metabolism genes and development of liver adenomas in males. We now demonstrate that obesity and aging precipi-
tate alterations of TRIM28-dependent transcriptional dynamics, leading to a metabolic infection state responsible for
highly penetrant male-restricted hepatic carcinogenesis. Molecular analyses implicate aberrant androgen receptor stimula-
tion, biliary acid disturbances, and altered responses to gut microbiota in the pathogenesis of Trim28hep–/–-associated
HCC. Correspondingly, androgen deprivation markedly attenuates the frequency and severity of tumors, and raising
animals under axenic conditions completely abrogates their abnormal phenotype, even upon high-fat diet challenge.
Conclusion: This work underpins how discrete polyphenic traits in epigenetically metastable conditions can contribute to a
cancer-prone state and more broadly provides new evidence linking hormonal imbalances, metabolic disturbances, gut
microbiota, and cancer. (HEPATOLOGY 2017;66:235-251).
Adverse dietary habits and aging represent cru-cial stress-inducing conditions detrimental tointernal homeostasis, ultimately increasing
the susceptibility of various tissues to metabolic disor-
ders and fostering oncogenic transformation.(1) The
burden of malignancies increases progressively in over-
weight and elderly people, both conditions promoting
a cancer-prone phenotype characterized by systemic
inﬂammation, increased oxidative stress, and altered
xenobiotic metabolism.(2) For certain organs, including
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the liver, the overall risk of cancer death is 4.5-fold
higher in men with a body mass index (BMI) exceed-
ing 40 kg/m2 and classiﬁed as obese.(3) The tumor-
promoting dynamics driven by stress-inducing factors
display a strong sex bias,(4) and the resulting imbalance
is especially evident for HCC, with a solid male pre-
dominance regardless of geographical area and ethnic-
ity.(5) Although both the protective role of estrogens
and the promoting effect of androgens on HCC devel-
opment are well documented,(6) little is known about
the underlying molecular mechanisms, although a
recent study implicates forkhead box protein A (Foxa)
transcription factors.(7)
Mammals are endowed with intrinsic homeostatic
plasticity, deﬁned as the ability to respond to external
stimuli by adjusting their metabolic phenotype to the
environment. This leads to adaptive changes aimed at
preserving tissue homeostasis through multiple and
elaborate organ-organ interactions. As a downside of
this trait, metabolic infection refers to a functional link
between the gut and distal organs, such as the liver,
whereby unfavorable products of the microbiota and
altered xenobiotic and bile acid metabolism become
pathogenic forces for the development of nonalcoholic
steatohepatitis (NASH) and liver cancer.(8)
How cells sense and respond to extrinsic cues relies
on dynamic transcriptional changes correlating with
extensive chromatin remodeling. Correspondingly, the
increased susceptibility to stress-inducing factors and
related diseases may arise, at least in part, from epige-
netically driven alterations in gene expression. A broad
range of chromatin changes can be observed in differ-
ent hepatocellular carcinoma (HCC) subtypes, and
even though they often converge toward the activation
of oncogenic pathways such as b-catenin, the mecha-
nistic connection is largely unexplained.(9) Each HCC
bears a unique mutational proﬁle, yet up to 50% harbor
mutations in some chromatin regulator.(10)
We previously identiﬁed tripartite motif-containing
28 (TRIM28; also known as transcription intermediary
factor 1-beta, KRAB-associated protein 1, or KRAB-
A-interacting protein 1), a scaffold protein capable of
recruiting a number of chromatin modiﬁers, as a crucial
mediator of sexual dimorphism in the liver, with hepato-
speciﬁc Trim28 deletion (Trim28hep–/–) in the mouse
leading to sex-speciﬁc transcriptional deregulation of a
wide range of bile and steroid metabolism genes and to
male-restricted development of liver adenomas.(11)
In the present work, we demonstrate that lack of
hepatic Trim28 expression engenders an epigenetically
unstable condition that severely compromises stress-
adaptation abilities. Trim28hep–/– mice exhibit altera-
tions of transcriptional dynamics exacerbated by envi-
ronmental insults, such as obesity and ageing, which
lead to altered sex hormone signaling, perturbations of
bile acids metabolism, intestinal dysbiosis, and a state
of metabolic infection that precipitate the development
of HCC.
Materials and Methods
MOUSE AND NUTRITIONAL
CHALLENGE
Mice were fed with standard mouse chow (Kliba
Nafag 3242 diet, Kilba Nafag, Kaiseraugst, Switzer-
land, irradiated >25 kGy, 3.85 kcal/g, and 10% kcal
from fat) or high-fat diet (HFD; Open Source Diets,
Research Diets, Inc., New Brunswick, NJ, USA,
D12331, irradiated twice >25 kGy; 5.56 kcal/g, and
58% kcal from fat) and water provided ad libitum. All
animal experiments were approved by the local veteri-
nary ofﬁce and carried out in accord with the European
Community Council Directive (86/609/EEC) for care
and use of laboratory animals. Mice were rederived to
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germ-free status by two-cell embryo transfer into pseu-
dopregnant germ-free recipient females. Germ-free
(GF) mice were bred and maintained in ﬂexible ﬁlm
isolators at the Clean Mouse Facility, University of
Bern (Bern, Switzerland). GF mice were routinely
monitored by culture-dependent and culture-
independent methods and were additionally conﬁrmed
to be pathogen free.
CHROMATIN
IMMUNOPRECIPITATION
SEQUENCING ANALYSIS
Trim28 chromatin immunoprecipitation sequencing
(ChIP-seq) was produced in our lab,(11) whereas andro-
gen receptor (AR) and Foxa1 ChIP-seq comes from.(7)
Reads were mapped to the murine genome assembly
(mm9) using Bowtie2(12) (the exact parameters are:
bowtie2 -t —sensitive-local -x $index -U $reads). The
peaks were called using the MACS program.(13)
RNA SEQUENCING ANALYSIS
Reads were mapped to the murine genome (mm9)
using TopHat(14) (v2.0.11) in sensitive mode (the exact
parameters are: tophat -g 1 —no-novel-juncs —no-
novel-indels -G $gtf —transcriptome-index $ transcrip-
tome —b2-sensitive $index $reads1 $reads2). Gene
counts were generated using HTSeq-count. Normaliza-
tion for sequencing depth and fold changes (for gene set
enrichment analysis [GSEA]) between groups of interest
were computed using Voom(15) because it has been
implemented in the limma package of Bioconductor.
STATISTICAL ANALYSIS
All data are expressed as means with error bars rep-
resenting the standard error of the means except for
the bacterial taxonomic analysis in Figure 7D where
the bars represent the 95% coefﬁcient of variation.
Outcomes on sufﬁciently metric scales (mRNA levels,
biomarkers levels, and percentage of total input) were
assessed with linear models (one- or two-way analysis
of variance [ANOVA]), modeling the mean value of
each group. Relevant comparisons of mean values
between two groups were made with two-sided pair-
wise t tests; the null hypotheses stated that there was
no difference in the means. P values were adjusted for
the number of comparisons by using the Bonferroni
method. Contingency testing was performed using
Fisher’s exact test.
Results
AGING AND OBESITY LEAD TO
MALE-RESTRICTED LIVER
CANCER IN Trim28hep–/– MICE
Trim28hep–/– animals were generated as reported on
a pure C57BL/6 background.(11) Deep-sequencing–
based transcriptome proﬁling of chow diet (CD)-fed
young animals revealed a dysregulation of 862 and 703
genes in male and female mice, respectively (Support-
ing Fig. S1A), with male-speciﬁc over-representation
of transcripts encoding for proteins involved in xenobi-
otic, bile acid (BA), and steroid metabolism, as
assessed by Gene Ontology (GO) and GSEA (Sup-
porting Fig. S1B,C).
We ﬁrst assessed the impact of aging on
Trim28hep–/– animals by keeping them on a CD for
73 weeks (Fig. 1A). This resulted in deregulation
of hepatic enzymes with male-speciﬁc signs of liver
dysfunction, such as hepatomegaly and increases in
circulating inﬂammatory cytokines (Supporting Fig.
S1D-G), albeit without frank steatosis (Fig. 1B).
Still, 7 of 9 of these mice, all male, bore malignant
lesions at the outset of the experiment (Fig. 1C
and Supporting Fig. S1H).
To determine whether the known contribution of
obesity to hepatic inﬂammation may set the stage for
HCC development in our model, we subjected mice to
a 27-week-long metabolic challenge of HFD enriched
in medium-chain fatty acids (MCFAs) derived from
hydrogenated coconut oil (58% calories from fat; calo-
ric density, 5.56 Kcal/g), starting at 8 weeks of age
(Fig. 1A). Likely attributable to up-regulation of lipo-
genic pathways, high doses of dietary MCFAs cause
higher degrees of hepatic steatosis (HS) and triglycer-
ide accumulation than lard-based HFD, which is
rather enriched in long-chain fatty acids (LCFAs).
MCFA-rich HFD triggered weight gain and HS, yet
these and other metabolic parameters, such as body fat
composition, food intake, and oral glucose tolerance
test were comparable between gender-matched
Trim28wt/wt and Trim28hep–/– mice (Fig. 1B and Sup-
porting Fig. S1I-O). However, absence of TRIM28
led to male-speciﬁc hepatomegaly (Fig. 1D and Sup-
porting Fig. S1P), progressive plasma dyslipidemia,
and abnormally elevated levels of hepatic enzymes
(Supporting Fig. S1Q). Furthermore, exposure to
HFD triggered a low-grade systemic inﬂammation
state in male Trim28hep–/– mice, characterized by both
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systemic increase in interleukin-6 (IL-6) and decreased
levels of the anti-inﬂammatory adipokine, adiponectin
(Fig. 1E and Supporting Fig. S1R).(16,17) Diet-
induced obesity also drove accelerated oncogenesis and
increased tumor burden in male Trim28hep–/– mice,
with 10 of 17 of these animals developing HCC
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whereas all others in the cohort remained tumor free
(Fig. 1F). Longitudinal in vivo assessment by micro-
computational tomography (l-CT) further delineated
a temporal window for emergence of macroscopically
visible cancer lesions, spanning between the sixteenth
week on HFD and the 27-week endpoint (Fig. 1G).
ABERRANT AR ACTIVATION IN
Trim28hep–/– TUMORS
Hepatocarcinogenesis is a complex process caused
by the accumulation of genetic and epigenetic changes.
In addition to its role during liver development, the
Wnt/b-catenin pathway has been identiﬁed as a key
player in metabolic zonation, BA homeostasis, and
drug detoxiﬁcation.(18) Furthermore, aberrant b-
catenin activation has been detected in HCC from
both human and rodents, with a mutation rate ranging
between 12% and 34% and anomalous expression
detected in up to 90% of neoplastic lesions.(9,10) Corre-
spondingly, immunohistochemistry (IHC)-based stud-
ies revealed the nuclear accumulation of b-catenin and
ectopic expression of its target gene, glutamine syn-
thase (gs),(19) in Trim28hep–/– neoplastic lesions (Fig.
2A, top and middle panels), and western blotting anal-
yses conﬁrmed increased levels of stabilized b-catenin
and hyperphosphorylation at serine 9 of its negative
regulator, glycogen synthase kinase 3-beta (GSK-3b;
Fig. 2B). Furthermore, upon confronting our tran-
scriptome results with publicly available data, GSEA
analyses positively correlated b-catenin targets, as
documented in liver of Apchep–/– mice, with the tran-
script repertoire of male Trim28hep–/– HCC (Fig. 2C),
which was also antithetical to b-catenin repressed tran-
scripts (Supporting Fig. S2A).
Strongly elevated levels of AR were documented by
IHC (Fig. 2A, bottom) and western blotting (Fig. 2B)
in Trim28hep–/– tumors. This resulted in aberrant
activation of AR-dependent pathways, as revealed by
the negative correlation between the transcriptome of
these dysplastic lesions and that of mice in which AR
signaling is severely compromised by Foxa1/2 knock-
out (Fig. 2D).(7) Accordingly, upon matching our
ChIP-seq results with publicly available data, we found
a relevant fraction of overlap between the binding sites
of TRIM28, AR, and FOXA1 at both promoters and
enhancers (91 and 452 peaks, respectively; Fig. 2E,F).
These included the regulatory regions of male-
restricted deregulated genes, such as the b-catenin tar-
get, CyclinD1 (Ccnd1),(20) the AR-direct target trans-
membrane protease serine 2 (Tmprss2),(21) and the
prosteatotic factor, cell-death–inducing DFFA-like
effector C (Cidec; Supporting Fig. S2B).(11) We asked
whether these deregulations might also partly result
from an imbalance of sex hormones, and found that
Trim28hep–/– males indeed exhibited elevated plasma
testosterone levels after 16 weeks of HFD (Fig. 2G).
This is consistent with the observation that biological
processes deregulated in male Trim28hep–/– animals
include steroid hormone metabolism and genes
required for androgen biosynthesis, such as cytochrome
P450 family 17 subfamily a member 1, a rate-limiting
enzyme for steroidogenesis and an important target for
treatment of prostate cancer (Supporting Fig. S2C).
ANDROGEN DEPRIVATION
THERAPY ALLEVIATES TUMOR
BURDEN
Abnormal androgen activity underlies many patho-
logical conditions, mainly represented by androgen-
dependent prostate cancer (PCa).(22) Androgen depri-
vation therapy (ADT) is currently the most effective
systematic treatment available for PCa patients.(23)
The increase in plasma testosterone, aberrant AR
expression, and activation of AR-responsive genes in
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FIG. 1. Environmental stress-inducing factors induce liver damage in Trim28hep–/– mice. (A) Experimental timeline procedure before
ﬁnal analysis. Weaning 5 green lines; CD 5 chow diet, in blue lines; HFD 5 high-fat diet, in red line (for long-term CD challenge,
n 5 10 for male Trim28hep–/– and n 5 9 for other groups; for the HFD challenge, n 5 16 for male Trim28wt/wt, n 5 17 for male
Trim28hep-/–, and n 5 10 for female cohorts). (B) Hematoxilin-eosin (H&E) and Oil Red O (ORO) stainings of liver samples from
long-term CD-fed (top panels) and HFD-fed (bottom panels) indicated animals; scale bars, 200 lm. (C) Tumor classiﬁcation graph
in livers of 73 wo CD-fed animals (FCA [focal cellular adhesion], HCC 5 1 single carcinoma, and HCC >1 multiple carcinomas).
*P value of male Trim28hep–/– versus Trim28wt/wt comparison 5 0.0004114 by Fisher’s exact test. (D) Liver-to-body weight ratios as
measure of hepatomegaly in HFD-fed animals. ***P < 0.001, by one-way ANOVA followed by Bonferroni’s posttest; ns, not signiﬁ-
cant. (E) Serum protein levels of proinﬂammatory cytokine IL-6 measured at different time points in HFD-fed male mice (n 5 10).
*P < 0.01, by two-way ANOVA followed by Bonferroni’s posttest. (F) Tumor classiﬁcation graph in livers of 35 wo HFD-fed ani-
mals. *P value of male Trim28hep–/– versus Trim28wt/wt comparison 5 0.008834 by Fisher’s exact test. (G) Representative anatomical
plane and three-dimensional reconstruction from l-CT analysis of male livers (red) performed 16 (top) or 27 weeks (bottom) after
receiving HFD. Sagittal (y-x), coronal (y-x), and transverse (z-x) planes are represented; tumor masses are indicated in blue and green.
Abbreviation: wo, weeks old.
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hepatic tumors of Trim28hep–/– animals prompted us to
explore the role of this pathway in the oncogenic pro-
cess. For this, we gelded 4-week-old Trim28hep–/– and
Trim28wt/wt mice and subjected them to our HFD
metabolic challenge (Fig. 3A). Bilateral orchiectomy
led to an effective reduction of plasma testosterone lev-
els (Supporting Fig. S3A). Body weight and fat com-
position increased to the same extent in both arms of
the cohort (Supporting Fig. S3B-D) with comparable
levels of daily food consumption (Supporting Fig.
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S3E), although anorchid animals had a reduced appe-
tite compared to age-matched controls (see Supporting
Fig. S1M), as described.(24) Neutered HFD-fed
Trim28hep–/– animals displayed progressive increases in
plasma levels of low-density lipoprotein (LDL)-cho-
lesterol and markers of hepatic inﬂammation, com-
pared to wild-type (wt) Trim28 controls (Fig. 3B,C
and Supporting Fig. S3F). Castration impacted on
tumor burden with a signiﬁcant reduction in number
and size of the lesions (Fig. 3D,E). Furthermore, his-
topathological analyses determined that neutered mice
only developed hepatocellular adenoma (HCA), con-
trasting with the high-frequency HCC observed in
gonad-endowed controls (Supporting Fig. S3G-L).
Nevertheless, despite a marked drop in circulating
androgens (Supporting Fig. S3M), anorchid
Trim28hep–/– HCA lesions presented the same tumor-
associated molecular patterns (TAMPs) as HCCs
found in control animals, with nuclear accumulation of
b-catenin, aberrant AR expression, and up-regulation
of their direct targets, Ccnd1 and Tmprss2, among
many (Fig. 3F,G). Thus, Trim28 deletion in the liver
appears to induce a cell-intrinsic defect that plays an
important role in the gene deregulations underlying
tumorigenesis.
TRIM28 INTERACTS WITH THE
AR/b-CATENIN AXIS
The persistence of AR signaling in a ligand-free
environment, as observed in HCA lesions of castrated
Trim28hep–/– animals, is reminiscent of the fate of
ADT-treated PCa patients, where an initial phase
of tumor shrinkage is followed by a hormone-
independent relapse. The molecular mechanisms
underlying progression to this castration-resistant stage
are heterogeneous, encompassing altered stability of
the AR coregulators with epigenetic alterations expos-
ing AR-regulated cryptic enhancers.(25) Moreover, in
cancer-prone settings, b-catenin interacts with the AR
to establish a dynamic cross-talk and enhance AR-
transcriptional activity.(26)
We used the human prostate carcinoma cell line,
22Rv1, to ask whether TRIM28 can serve as a partner
for the AR/b-catenin axis. Upon dihydrotestosterone
(DHT) stimulation of these cells, AR translocated to
the nucleus where it colocalized with TRIM28 (Sup-
porting Fig. S4A). In vitro glutathione S-transferase
(GST) pull-down assays using recombinant TRIM28
(Supporting Fig. S4B) revealed a DHT-dependent
association with AR mediated by the RING-B box-
coiled coil (RBCC) domain (Fig. 4A), but indepen-
dent from serine residues known to serve as phosphor-
ylation targets (Supporting Fig. S4C). TRIM28 could
also be immunoprecipitated in PCa cells with AR,
FOXA1, and b-catenin upon DHT stimulation (Fig.
4B). Furthermore, TRIM28 was recruited in this set-
ting to a subset of AR-binding elements (AREs)
located in genes deregulated in tumors of male
Trim28hep–/– animals (Fig. 4C). In contrast, no such
TRIM28 recruitment at AREs was detected in the
androgen-independent PC3 cell line (Fig. 4D).
Finally, conﬁrming that TRIM28 can interfere with
the association of AR/FOXA1 with b-catenin, the
latter interacted with the former two in Trim28hep–/–
hepatocellular neoplastic lesions, but not in healthy
tissue (Fig. 4E).
BA DYSREGULATION AND
FARNESOID X RECEPTOR
ATTENUATION IN Trim28hep–/–
MICE
GO analysis of dysregulated transcripts (2-fold
change; P < 0.05) indicated that loss of TRIM28
affected molecular functions and biological processes
involved in BA metabolism (see Supporting Fig. S1B,
C). BAs are produced and conjugated in hepatocytes,
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FIG. 2. TAMPs characterization of male Trim28hep–/– hepatocarcinogenesis. (A) Diaminobenzidine staining of liver sections for b-
Catenin (top panels), Glutamine Synthase (GS; middle panels), and AR (bottom panels). NT, parenchyma; T, tumor; scale bar, 200
lm. (B) Western blotting analysis of indicated proteins on liver and tumor lysates from HFD-fed animals. b-actin was used as inter-
nal loading control. One representative experiment of three is represented. (C) Plot of GSEA analysis of up-regulated (left) and
down-regulated (right) genes in Trim28hep–/– tumors with genes deregulated in Apchep–/– livers (fold change [FC], >5; P < 0.05).
NES, normalized enrichment score; fdr, false discovery rate. (D) Plots of GSEA analysis of up-regulated (left) genes in Trim28hep–/–
tumors with genes deregulated in diethylnitrosamine-treated FoxA1hep–/– livers (FC, >5; P < 0.05), showing the anticorrelation of
male Trim28hep–/– transcriptome with a model of AR signaling attenuation. NES, normalized enrichment scores; fdr, false discovery
rate. (E,F) Venn diagram illustrating the degree to which TRIM28, FOXA1, and AR peaks are overlapping in liver tissues when
limiting the analysis to gene promoter (E; 65 kbp TSS) or regulatory regions (F; 650 kbp TSS). (G) Serum testosterone levels of
indicated groups measured 16 (left) or 27 weeks (right) after receiving HFD (n 5 15 for males and n 5 10 for females). *P < 0.05;
***P < 0.001, by one-way ANOVA followed by Bonferroni’s posttest. Values are calculated as mean 6 SEM. Abbreviations: kbp,
kilobase pairs; TSS, transcription start sites.
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stored in the gallbladder, and, ﬁnally, released in the
duodenum to facilitate absorption of food and vitamins.
They are increasingly being appreciated as complex
metabolic integrators and signaling factors, and their
aberrant accumulation can promote carcinogenesis.(27)
Liquid chromatography and mass spectrometry
analyses revealed a substantial increase of BAs in the
liver of both na€ıve and anorchid HFD-fed male
Trim28hep–/– mice (Fig. 5A,B). Taken individually,
tauro-alpha-muricholic acid (T-aMCA), tauro-beta-
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muricholic acid (T-bMCA), and taurocholic acid
(TCA) were the most abundant species in both HFD-
fed Trim28wt/wt and Trim28hep–/– animals (Fig. 5CD).
Consistent with their tumorigenic phenotype, aberrant
BA accumulation was also documented in aged
Trim28hep–/– animals (Supporting Fig. S5A,B). Livers
from male Trim28hep–/– exhibited abnormally elevated
levels of T-bMCA (151% for HFD-fed neutered,
1102% for HFD-fed gonad-endowed, and 1314%
for aged mice) compared to their wt counterparts. T-
bMCA acts as an antagonist of the nuclear farnesoid X
receptor (FXR),(28) which has hepatoprotective and
tumor-suppressor effects. Fxr knockout (Fxr–/–) mice
present with elevated BA levels, hepatosteatosis, and
100% of late-onset b-catenin-dependent HCC.(29)
FXR expression was markedly decreased in TRIM28-
less livers and was almost undetectable in cancer tissue
lesions (Fig. 5E). This was paralleled by the down-
regulation of its main downstream target, small hetero-
dimer partner (SHP; Fig. 5E). Attributable to their
small size, it was impossible to analyze protein expres-
sion from Trim28hep–/– HCAs, but we observed a neg-
ative correlation with FXR and SHP expression when
analyzing the surrounding nontumor tissue (Support-
ing Fig. S5C). Conﬁrming the phenotypic parallels
between liver-speciﬁc Trim28 and Fxr knockouts,(30)
GSEA analysis revealed a marked correlation between
transcripts deregulated in the two settings, whether
considering Trim28hep–/– nontumoral liver or HCC
lesions (Fig. 5F and Supporting Fig. S5D).
PHENOTYPE SEVERITY
CORRELATES WITH BACTERIAL
VARIATIONS AND DYSBIOSIS
The gut microbiota is emerging as a dynamic envi-
ronmental factor exquisitely sensitive to metabolic per-
turbations, such as dietary obesity, and detrimental
inﬂuences through the enterohepatic axis can, in turn,
play a role in obesity-associated cancer.(31) We used
16S ribosomal RNA gene amplicon sequencing to
characterize the gut microbiota of HFD-fed wt and
Trim28hep–/– mice with or without castration. We
found that the obesogenic regimen progressively
increased the relative representation of Firmicutes at
the expense of the Bacteroidetes as reported,(32) without
striking differences detected between genotypes (Fig.
6A). However, linear discriminant analysis (LDA)
effect size (LEfSe) results revealed different degrees of
operational taxonomic unit (OTU) deregulation
between HCA- and HCC-bearing Trim28hep–/– mice
(Fig. 6BC), with a near 4-fold increase of OTU vari-
ability in cases of more advanced tumors (51 in HCC-
vs. 14 deregulated OTUs in HCA-bearing animals).
Aging induced levels of microbiota perturbation com-
parable to obese Trim28hep–/– animals carrying malig-
nant lesions (54 deregulated OTUs; Supporting Fig.
S6A,B). When comparing microbial communities of
HFD-fed gonad-endowed and anorchid mutant mice,
intermediate levels of microbial variation (35 deregu-
lated OTUs) were recorded, correlating with the atten-
uation of the tumorigenic phenotype by castration
(Supporting Fig. S6C,D).
Fecal microbial communities from HCC-bearing
Trim28hep–/– mice displayed signiﬁcant increases in the
Prevotellaceae family, which are considered as hallmarks
of dysbiosis and frequently altered in patients with cir-
rhosis. The abundance of Clostridiaceae, Peptostrepto-
coccaceae, and Lactobacillaceae was signiﬁcantly higher
in HCC-bearing Trim28hep–/– mice, a condition also
observed in HFD-induced intestinal carcinogenesis.(33)
Tumor severity correlated with the speciﬁc down-
regulation of the mucin-degrading bacteria, Akkerman-
sia muciniphila (Fig. 6D, left), a bacterial strain
associated with the improvement of obesity-related
metabolic and immune alterations.(34) Conversely, we
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FIG. 3. Orchiectomy alleviates tumor burden with persistence of AR signaling. (A) Experimental timeline procedure for the HFD chal-
lenge of neutered animals (n5 10). Bilateral orchiectomy was performed at 4 wo and HFD started at 8 wo until ﬁnal analysis at 35 weeks.
(B,C) Serum ALT (B) and AST (C) activity in gonad-endowed (black-lined bars) and castrated (1NEUT, blue-lined bars) animals at
different timepoints. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001, by two-way ANOVA followed by Bonferroni’s posttest. (D)
Tumor classiﬁcation graph in livers of gonad-endowed and neutered Trim28hep–/– mice (1NEUT) after HFD challenge. *P value of the
Trim28hep–/– versus Trim28hep–/–1NEUT comparison 5 0.001611, by Fisher’s exact test. (E) Left: tumor size graph in gonad-
endowed (ﬁlled circle) and neutered (open circle) Trim28 mutant mice. *P value of the Trim28hep–/– versus Trim28hep–/–1NEUT
comparison 5 0.0003572, by Fisher’s exact test. Right: representative pictures of cancer lesions from gonad-endowed (bottom) and
anorchid (top, adenoma circled in red) mice. (F) H&E and diaminobenzidine stainings for Glutamine Synthase, b-CATENIN,
and AR in HCA of neutered Trim28hep–/– animals. NT, parenchyma; T, tumor. (G) qPCR on liver and tumor biopsies for Ccnd1
and Tmprss2 expression as direct targets of b-catenin and AR, respectively. Values are calculated as mean relative expression after
normalization to three housekeeping genes 6 SEM; *P < 0.05; **P < 0.01; ****P < 0.0001, by one-way ANOVA followed by
Bonferroni’s posttest. Abbreviations: a.u., arbitrary units; H&E, hematoxylin-eosin; wo, weeks old.
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FIG. 4. Biochemical characterization of TRIM28-associating partners. (A) Puriﬁed recombinant wt or GST-TRIM28 deletion
mutants were incubated with 22Rv1 cell lysates, and the pull-down complexes were analyzed by western blotting with the indicated
antibodies. As a positive control, pull-down complexes were incubated with HP1c antibody. Recombinant GST-HP1c was used as
negative control for AR interaction. n 5 4. (B) IPs were performed using nuclear extracts (NEs) prepared from methanol-stimulated
(Veh) or DHT-stimulated 22Rv1 cells using antibodies against TRIM28, b-CATENIN, FOXA1, and AR. IP complexes were ana-
lyzed by western blotting using indicated antibodies. (C,D) 22Rv1 (C) or PC3 (D) cells were stimulated for 1 or 16 hours with DHT
or vehicle alone (Veh). Chromatin was immunoprecipitated with antibodies recognizing TRIM28, AR, and IgG as a negative control
and quantitated by qPCR using primer sets speciﬁc for indicated genomic regions. Gapdh promoter region was used as negative con-
trol. Values are represented as mean 6 SEM as a percentage of the input chromatin; n 5 3, *P < 0.05; **P < 0.01; ns (not signiﬁ-
cant), by two-way ANOVA followed by Bonferroni’s posttest. (E) In vivo IPs were performed on protein extract from livers and
tumors of Trim28wt/wt and Trim28hep–/– mice incubated with antibodies against FOXA1 (top panels), b-CATENIN (middle panels),
and AR (bottom panels), and the resulting eluates were analyzed by western blotting with the indicated antibodies. Abbreviations:
Gapdh, glyceraldehyde-3-phosphate dehydrogenase; HP1c, heterochromatin protein 1-gamma; IgG, immunoglobulin G; IPs, immu-
noprecipitations; Veh, vehicle.
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FIG. 5. TRIM28 loss causes BA dysregulation and FXR signaling attenuation. (A,B) Absolute quantiﬁcation of hepatic BA content in
HFD-fed gonad-endowed (A) and castrated (B) mice (n 5 15 for males and n 5 10 for other groups). Values are normalized per pro-
tein content and per mg of tissue and expressed as mean 6 SEM. *P < 0.05; ***P < 0.001, by two-way ANOVA followed by Bonferro-
ni’s posttest. (C,D) Hepatic BA species composition in gonad-endowed (C) and castrated (D) mice. T– 5 tauro-conjugated species;
aMCA, alpha-muricholic acid; bMCA, beta-muricholic acid; CA, cholic acid; CDCA, chenodeoxycoholic acid; DCA, deoxycholic acid;
HDCA, hyodeoxycholic acid; UDCA, ursodeoxycholic acid. Values are normalized per protein content and per mg of tissue and
expressed as mean 6 SEM. **P<0.01; ****P < 0.0001, by two-way ANOVA followed by Bonferroni’s posttest. (E) Western blotting of
liver and tumor lysates of gonad-endowed HFD-fed mice incubated with the indicated antibodies. For FXR quantiﬁcation, band intensi-
ties were normalized to b-actin and calculated as percentage relative to Trim28wt/wt liver sample. (F) Plot of GSEA analysis showing a
positive correlation between down-regulated genes in HFD-fed Trim28 mutant livers and FXR-dependent targets (FC, >5; P < 0.05).
Abbreviation: FC, fold change; fdr, false discovery rate; NES, normalized enrichment scores; pSHP, phosphorylated SHP.
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found that still poorly characterized strains, such as the
Clostridiaceae SMB53, were particularly abundant in
HCC-bearing Trim28hep–/– mice (Fig. 6D, right).
Once established, overall patterns of alpha diversity
across HCA- and HCC-bearing mice were stable and
consistent at all the time points analyzed (Supporting
                                                                                                                                      
FIG. 6
                                                                                                                                      
CASSANO ET AL. HEPATOLOGY, July 2017
246
Fig. S6E,F). Furthermore, qPCR on genomic liver
DNA with universal 16S RNA primer sets indicated
no sign of hepatic bacterial invasion (Supporting Fig.
S6G). Finally, lipopolysaccharide (LPS) systemic levels
measured by enzyme-linked immunosorbent assay
revealed no endotoxemia in obese Trim28hep–/– mice
(Supporting Fig. S6H).
HEPATOCARCINOGENESIS IS
SUPPRESSED BY AXENIC
CONDITIONS
Dysbiosis can contribute to liver disease and com-
pelling evidence links the enteric microbiome with
inﬂammation- and obesity-associated hepatocarcino-
genesis.(8,35) Based on this premise, we repeated the
HFD challenge in mice raised in GF conditions. No
difference in body weight was observed between sex-
matched genotypes (Supporting Fig. S7A,B). In line
with previous reports,(36) GF animals gained less
weight than their conventionally raised counterparts,
and in this environment Trim28hep–/– males displayed
neither hepatomegaly (Fig. 7A and Supporting Fig.
S7C) nor elevation of plasma transaminases, although
a signiﬁcant accumulation of LDL-cholesterol was
noted (Fig. 7B and Supporting Fig. S7D). Further-
more, they presented no increase in serum levels of
proinﬂammatory cytokine IL-6 and no decrease in
anti-inﬂammatory adipokine adiponectin (Fig. 7C,D).
Finally, 15 of 15 Trim28hep–/– male GF mice remained
tumor free for the entire time of the experiment, only 1
case of liver cancer being observed in 1 of 10 Trim28-
hep–/– females, albeit without the TAMPs recorded in
all other cases of HCA or HCC (Fig. 7E and data not
shown). Accordingly, qPCR analysis revealed no sig-
niﬁcant up-regulation of AR and b-catenin gene tar-
gets (Fig. 7F), no aberrant hepatic BA content (Fig.
7G and Supporting Fig. S7E), and no deregulation of
FXR or SHP (Fig. 7H and Supporting Fig. S7F,G).
Discussion
This study demonstrates that hepatic ablation of a
master epigenetic regulator leads to the sex-speciﬁc
development of a polyphenic trait fostered by age and
obesity and characterized by altered hormonal signal-
ing, dysbiosis, and a state of metabolic infection pre-
cipitating the occurrence of HCC. Diverging from the
simplistic one gene/one phenotype relationship, the
hereby described consequences of hepatic TRIM28
ablation do not imply that this represents a common
genetic basis of malignancy, but serve as a remarkable
model for increased vulnerability to cancer. Our data
indeed support a major role for epigenetic regulation in
adaptive metabolic plasticity(37,38) and reveal TRIM28
as an important factor in the ability of higher organ-
isms to cope with environmental stress. Our work also
indicates causative links between the gut microbiota
and liver cancer and provides not only an attractive
preclinical model for studying this dreadful disease, but
also leads for research toward its prevention and possi-
bly its treatment.
The phenotype displayed by Trim28hep–/– mice
presents many similarities with human liver cancer,
whether in terms of clinical course or molecular hall-
marks. In contrast with the abrupt pathology observed
in preclinical models relying on the administration of
carcinogenic substances, the liver-speciﬁc deletion of
TRIM28 leads to a slowly progressive, multistep dis-
ease, with a detectable role for established or suspected
contributors of human nonalcoholic fatty liver disease
(NAFLD) and hepatocarcinoma, such as obesity,
microbiota, and aging, some of which at least are
actionable both in this model and in the clinics. As
well, the nuclear accumulation of b-catenin character-
izes the vast majority of human HCCs, and AR signal-
ing is commonly activated in human liver tumors,
pointing to the relevance of Trim28hep–/– mice for
research aimed at discovering and stratifying new ther-
apies for liver cancer.
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FIG. 6. Microbiota dynamics correlates with tmor phenotype. (A) Fecal microbiota composition at the phyla level of Trim28wt/wt and
Trim28hep–/– fecal stool at 0, 16, and 27 weeks from HFD diet. 1NEUT, anorchid mice. (B) Cladograms generated from LEfSe
analysis representing enriched (red) and reduced (green) taxa in fecal microbiota of HCC-bearing (top) or HCA-bearing (bottom)
Trim28hep–/– mice. The central point represents the root of the tree (bacteria), and each ring represents the next lower taxonomic level
(phylum through species). The diameter of each circle represents the relative abundance of the taxon. When full identiﬁcation was not
possible, g_ or s_ alone was used for genus or species, respectively. (C) LDA scores of the differentially abundant taxa shown in clado-
grams. Taxa enriched or reduced in microbiota from Trim28hep–/– mice are indicated with a positive (red) or negative (green) LDA
score, respectively. (D) Relative abundances of Akkermansia muciniphila (left) and Clostridiaceae SMB53 (right) in Trim28wt/wt (green)
and Trim28hep–/– (red) mice receiving HFD for 16 and 27 weeks. Values are expressed as mean 6 95% conﬁdence interval. n per
group indicated at the bottom of the graph.
HEPATOLOGY, Vol. 66, No. 1, 2017 CASSANO ET AL.
247
We had previously observed that hepato-speciﬁc
ablation of Trim28 led to sex-speciﬁc transcriptional
deregulation of a wide range of xenobiotic and steroid
metabolism genes, and to the male-limited develop-
ment of liver adenomas, with low baseline penetrance
moderately increased on conventional, lard-rich
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HFD.(11) Encouraged by these ﬁndings, we brought
several modiﬁcations to our experimental protocol.
First, we moved from a genetically mixed to a pure
C57BL/6 background. Second, we extended the time
of the study to assess the impact of aging. Third, we
subjected animals to a more challenging diet, enriched
in highly prosteatotic MCFAs.
Time alone had a strong inﬂuence on the pathologic
phenotype of Trim28hep–/– mice, leading to highly pen-
etrant male-speciﬁc carcinogenesis. This was associ-
ated with signs of both local and systemic
inﬂammation, with elevated levels of hepatotoxicity
markers such alanine aminotransferase (ALT) and
aspartate aminotransferase (AST), the release of proin-
ﬂammatory cytokines, and a drop in their anti-
inﬂammatory counterparts. Our study endpoint of 73
weeks corresponds to a mid-elderly stage, considering
an average life span of 110 weeks for conventionally
raised C57BL/6 mice.(39) It likely reﬂected the cumu-
lative impact of age-related factors, such as increased
DNA-damage by reactive oxygen species produc-
tion.(40) A high BMI precipitates the aging of liver tis-
sue, qualifying obesity as an accelerator of the hepatic
epigenetic clock, as deﬁned according to the DNA
methylation status of a few hundred selected CpG
dinucleotides.(41) Obesity is also an epidemiologically
established risk factor for HCC, and is associated with
inﬂammation and NAFLD. Here, it had a dramatic
effect, increasing both the rate of appearance and over-
all frequency of HCC in Trim28hep–/– mice.
TRIM28 is a member of the RBCC protein family
that is devoid of DNA-binding ability but can be teth-
ered to the genome by a variety of partners, amongst
which hundreds of KRAB-containing zinc ﬁngers
(KZFPs).(42) It generally serves as a scaffold for the
assembly of macromolecular complexes containing
diverse chromatin modiﬁers, including histone methyl-
transferases, histone acetylases and deacetylases, as well
as nucleosome remodeling factors. Initially identiﬁed
as a corepressor,(43) notably found responsible for the
early embryonic silencing of KZFP-targeted endoge-
nous endogenous retroelements,(44) TRIM28 has since
been demonstrated to be capable of acting also as a
coactivator(45) and has been implicated not only in
transcriptional regulation, but also in DNA repair and
maintenance of heterochromatin during genome
replication.(46,47)
Within the inﬂammatory context triggered by aging
or obesity, the alterations of Trim28-dependent tran-
scriptional dynamics resulted in activating TAMPs,
with attenuation of FXR signaling, hyperactivation of
b-catenin, and altered AR signaling. Our analyses sug-
gest that TRIM28 association with b-catenin and
FOXA1/AR normally prevents the illegitimate activa-
tion of this TAMP, a ﬁnding corroborated by the
aberrant activation of AR signaling in Trim28hep–/–
mice, and the partially protective effect of androgen
deprivation on their tumorigenic phenotype, with few
anorchid mutant males developing small benign neo-
plasms. Whereas this partly explains the male exclu-
siveness of the pathology triggered by TRIM28
hepatic ablation, persistently altered AR signaling in
this setting is consistent with the long-term limitations
of androgen depletion in both HCC and castration-
resistant prostate cancer; yet it suggests that other
approaches interfering with AR signaling might suc-
ceed in slowing down liver cancer progression.(6,25)
Initially only considered as mediators of food and
vitamin absorption, BAs are emerging as important
signaling factors along the gut-liver axis, and perturba-
tion of their homeostasis can have major detrimental
consequences, including the promotion of gastrointes-
tinal cancer.(27,31) Consistent with the deregulation of
genes encoding for factors involved in BA metabolism
and secretion, both obese and aged males lacking
TRIM28 in the liver displayed an aberrant
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FIG. 7. Axenic conditions rescue both the inﬂammatory and cancer phenotype of Trim28hep–/– animals. (A) Liver-to-body weight
ratios in germ-free (GF) HFD-fed indicated animals (n 5 10 for female Trim28hep–/–; n 5 15 for all other groups). *P < 0.05; ns
(not signiﬁcant), by one-way ANOVA followed by Bonferroni’s posttest. (B) Serum ALT (left) and AST (right) activity of GF
HFD-fed animals. Ns 5 not signiﬁcant, by two-way ANOVA followed by Bonferroni’s posttest. (C,D) Serum IL-6 (C) and adipo-
nectin (D) levels in GF mice receiving HFD for 27 weeks (n 5 7 per group). ns (not signiﬁcant), by two-way ANOVA followed by
Bonferroni’s posttest. (E) Tumor classiﬁcation graph in livers of GF HFD-fed animals (n 5 10 for female Trim28hep–/–; n 5 15 for
all other groups). (F) qPCR on liver samples for direct targets of AR (Tmprss2 and Rhou1) and b-catenin (Cnnd1 and Lef1). Values
are calculated as mean relative expression after normalization to three housekeeping genes 6 SEM; ns (not signiﬁcant), by one-way
ANOVA followed by Bonferroni’s posttest. (G) Absolute quantiﬁcation of hepatic BA content in male GF Trim28wt/wt (ﬁlled circle)
and Trim28hep–/– (open circle) mice after receiving HFD for 27 weeks. Values are normalized per protein content and per mg of tissue
and expressed as mean 6 SEM; ns (not signiﬁcant), by two-way ANOVA followed by Bonferroni’s posttest. (H) Western blotting
analysis for FXR, phospho-, and total-SHP expression in liver samples from GF animals receiving HFD for 27 weeks. b-actin was
used as internal loading control. One experiment of three is shown. Abbreviations: a.u., arbitrary units; pSHP, phosphorylated SHP;
Rhou1, Ras homolog family member U1.
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accumulation of tauro-conjugated bile acids, particu-
larly the FXR-antagonist, T-bMCA. FXR is a recog-
nized hepatic tumor suppressor,(29) and Trim28hep–/–
and Fxr–/– mice present striking phenotypic similari-
ties, with deletion of the nuclear-receptor–inducing
elevated triglycerides, ALT, AST, and hepatic BA lev-
els, and spontaneous development of b-Catenin-
dependent HCCs at >1 year of age.(29,48) This
strongly suggests that the synergistic inﬂuences of ele-
vated BA concentrations and hepatic FXR inactivation
expose TRIM28-less hepatocytes to a microenviron-
ment that fuels inﬂammation and promotes
tumorigenesis.
Mounting evidence links dietary factors with altera-
tions of the gut microbiota, potentially resulting in
dysbiosis and increased intestinal permeability.(8,32,33)
Most xenobiotics are metabolized in the liver, and
alteration of this process can impede the detoxiﬁcation
of oncogenic metabolites. The intestinal ﬂora can thus
impact on hepatic functions by promoting inﬂamma-
tion and tumorigenesis. In turn, by-products of altered
hepatic metabolism can inﬂuence the composition of
the gut microbiota.(8,35) Here, we observed that HCC-
bearing TRIM28-deﬁcient animals, being obese or
aged, exhibited deregulation of more than 50 bacterial
species compared to their wt, tumor-less counterparts,
4-fold more than counted in HCA-bearing anorchid
animals. In Trim28hep–/– mice with HCC, taxonomic
species previously related to metabolic dysfunction and
inﬂammation, such as Prevotella, Akkermansia mucini-
phila, and Bacteroides uniformis,(34,35,49) were promi-
nently deregulated, as were some other species not
previously associated with any pathologies, such as
Clostridiaceae SMB53.
Demonstrating the critical role of the gut microbiota
in the genesis of HCC in our model, the pathological
phenotype of Trim28hep–/– mice was completely abro-
gated when they were raised in axenic conditions. In
this environment, in spite of their mutant genotype,
these animals displayed no sign of hepatic inﬂamma-
tion, no perturbation of serum IL-6 and adiponectin
levels, no activation of TAMPs nor drop in FXR and
its SHP target, and, most important, no tumor devel-
opment after 27 weeks on strongly prosteatotic HFD,
a time at which 60% of their conventionally raised con-
trols exhibited macroscopically visible HCC lesions.
Thus, the intestinal ﬂora represents an obligatory fac-
tor in the development of liver cancer in our model.
Although our data do not formally identify microbial
oncogenic drivers nor determine whether the accumu-
lation of BAs modulates the growth of deﬁned
bacterial species, the use of gnotobiotic models or BA-
enriched regimens could help address these questions.
More generally, the present work warrants efforts
aimed at characterizing the gut microbiota of patients
presenting with states known to predispose to liver
cancer, as well as at exploring the potential of its
manipulations for the prevention and treatment of this
disease.
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